20-62656485-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016354.4(SLCO4A1):c.31C>T(p.Leu11Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000828 in 1,522,118 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016354.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLCO4A1 | NM_016354.4 | c.31C>T | p.Leu11Phe | missense_variant | 2/12 | ENST00000217159.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLCO4A1 | ENST00000217159.6 | c.31C>T | p.Leu11Phe | missense_variant | 2/12 | 1 | NM_016354.4 | P1 | |
SLCO4A1 | ENST00000370507.5 | c.31C>T | p.Leu11Phe | missense_variant | 1/11 | 1 | P1 | ||
SLCO4A1 | ENST00000497209.5 | c.31C>T | p.Leu11Phe | missense_variant, NMD_transcript_variant | 2/10 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152236Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000222 AC: 36AN: 162246Hom.: 0 AF XY: 0.000296 AC XY: 26AN XY: 87758
GnomAD4 exome AF: 0.0000796 AC: 109AN: 1369882Hom.: 0 Cov.: 32 AF XY: 0.0000832 AC XY: 56AN XY: 672674
GnomAD4 genome AF: 0.000112 AC: 17AN: 152236Hom.: 0 Cov.: 34 AF XY: 0.000108 AC XY: 8AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 02, 2022 | The c.31C>T (p.L11F) alteration is located in exon 2 (coding exon 1) of the SLCO4A1 gene. This alteration results from a C to T substitution at nucleotide position 31, causing the leucine (L) at amino acid position 11 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at